Roche Resources is intended for UK Healthcare Professionals only. By entering this site you are confirming that you are a UK Healthcare professional.
ALECENSA® (alectinib) Great Britain
ALECENSA® (alectinib) Northern Ireland
Avastin® (bevacizumab) Great Britain
Avastin® (bevacizumab) Northern Ireland
Evrysdi®▼ (risdiplam) Great Britain
Evrysdi®▼ (risdiplam) Northern Ireland
GAVRETO® ▼ (pralsetinib) Great Britain
GAVRETO® ▼ (pralsetinib) Northern Ireland
GAZYVARO® (obinutuzumab) Great Britain
GAZYVARO® (obinutuzumab) Northern Ireland
HEMLIBRA® (emicizumab) Great Britain
HEMLIBRA® (emicizumab) Northern Ireland
Herceptin® (trastuzumab) IV
Herceptin® (trastuzumab) SC
Kadcyla®(trastuzumab emtansine)
Lunsumio®▼ (mosunetuzumab) Great Britain
Lunsumio®▼ (mosunetuzumab) Northern Ireland
OCREVUS® (ocrelizumab) Great Britain
OCREVUS® (ocrelizumab) Northern Ireland
Perjeta® (pertuzumab)
PHESGO®▼ (pertuzumab/trastuzumab)
Polivy®▼ (polatuzumab vedotin) Great Britain
Polivy®▼ (polatuzumab vedotin) Northern Ireland
Rozlytrek®▼ (entrectinib) Great Britain
Rozlytrek®▼ (entrectinib) Northern Ireland
TECENTRIQ® (atezolizumab) Great Britain
TECENTRIQ® (atezolizumab) Northern Ireland
Vabysmo®▼ (faricimab) Great Britain
Vabysmo®▼ (faricimab) Northern Ireland
Gavreto and Rozlytrek are subject to a conditional marketing authorisation.
Medicinal products that display the black triangle symbol ▼ are subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Roche Products Ltd. Please contact Roche Drug Safety Centre by emailing welwyn.uk_dsc@roche.com or calling +44 (0)1707 36 7554. For medicines which are biological, healthcare professionals should report adverse reactions by brand name and batch number.
You are about to leave the rocheresources.co.uk environment and will be redirected to another site or resource which may contain information not intended for a UK audience. Roche Products Limited does not endorse or accept liability for sites or resources controlled by third parties.